Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
chitosan (1 trial)
vs-505 (1 trial)
Hyperphosphatemia (Phase 2)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Trials (2 total)
Trial APIs (2 total)